Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Total Debt (2020 - 2025)

Historic Total Debt for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $322.6 million.

  • Bioventus' Total Debt fell 1590.33% to $322.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $322.6 million, marking a year-over-year decrease of 1590.33%. This contributed to the annual value of $335.6 million for FY2024, which is 1499.8% down from last year.
  • Bioventus' Total Debt amounted to $322.6 million in Q3 2025, which was down 1590.33% from $341.2 million recorded in Q2 2025.
  • Bioventus' Total Debt's 5-year high stood at $445.6 million during Q2 2023, with a 5-year trough of $177.4 million in Q4 2021.
  • For the 5-year period, Bioventus' Total Debt averaged around $347.9 million, with its median value being $374.0 million (2022).
  • In the last 5 years, Bioventus' Total Debt soared by 13918.57% in 2022 and then tumbled by 1590.33% in 2025.
  • Over the past 5 years, Bioventus' Total Debt (Quarter) stood at $357.7 million in 2021, then grew by 16.88% to $418.1 million in 2022, then dropped by 5.55% to $394.8 million in 2023, then fell by 15.0% to $335.6 million in 2024, then decreased by 3.89% to $322.6 million in 2025.
  • Its Total Debt stands at $322.6 million for Q3 2025, versus $341.2 million for Q2 2025 and $345.9 million for Q1 2025.